検索結果 - Eulalia Jiménez
- 検索結果 1 - 4 結果 / 4
-
1
#2267 IL-33 Inhibition with tozorakimab for diabetic kidney disease: a randomized, placebo-controlled phase 2b study 著者: Hiddo J.L. Heerspink, Alexis Hofherr, Kaisa Mäki-Petäjä, Viknesh Selvarajah, Daniel Grice, Stefano Bartesaghi, Eulalia Jiménez, Nitin Kaila, Roberto Pecoits–Filho
出版事項 2024Artigo -
2
Population pharmacokinetic/target engagement modelling of tozorakimab in healthy volunteers and patients with chronic obstructive pulmonary disease 著者: Muhammad Waqas Sadiq, Hongtao Yu, Magnus Åstrand, Ian C. Scott, Adam Williams, Lisa Hewitt, N. E. White, Helen Killick, Monica L. Gavala, E. Suzanne Cohen, Fred Reid, Chris Kell, Hitesh Pandya, Eulalia Jiménez
出版事項 2024Artigo -
3
A phase 2a trial of the IL-33 mAb tozorakimab in patients with COPD: FRONTIER-4 著者: Dave Singh, Patricia Guller, Fred Reid, Sarah Doffman, Ulla Seppälä, Ioannis Psallidas, Rachel Moate, Rebecca Smith, Joanna Kiraga, Eulalia Jiménez, Dennis E. Brooks, Aoife Kelly, Lars H. Nordenmark, Muhammad Waqas Sadiq, Luis Mateos Caballero, Chris Kell, Maria G. Belvisi, Hitesh Pandya
出版事項 2025Artigo -
4
A Randomized Phase I Study of the Anti‐Interleukin‐33 Antibody Tozorakimab in Healthy Adults and Patients With Chronic Obstructive Pulmonary Disease 著者: Fred Reid, Dave Singh, Muna Albayaty, Rachel Moate, Eulalia Jiménez, Muhammad Waqas Sadiq, David Howe, Monica L. Gavala, Helen Killick, Adam Williams, Surekha Krishnan, A. Godwood, Animesh Shukla, Lisa Hewitt, Alejhandra Lei, Chris Kell, Hitesh Pandya, Paul J. Newcombe, N. E. White, Ian C. Scott, E. Suzanne Cohen
出版事項 2023Artigo
関連主題
Internal medicine
Medicine
Chemistry
Antibody
Gastroenterology
Immunology
Organic chemistry
Phase (matter)
Pulmonary disease
Randomized controlled trial
Alternative medicine
Archaeology
Bioavailability
Biochemistry
Biomarker
COPD
Confidence interval
Disease
Dosing
Environmental health
Frontier
History
Monoclonal antibody
NONMEM
Pathology
Pharmacokinetics
Pharmacology
Placebo
Population
Volume of distribution